These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6299608)

  • 41. [Effect of 4-aminopyridine on synaptic transmission in the smooth muscle of the gastrointestinal tract of the guinea pig and man].
    Zagorodniuk VP; Shuba MF
    Fiziol Zh (1978); 1986; 32(4):419-24. PubMed ID: 3017771
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of thiamine, thiamine phosphates, and flavin adenine dinucleotide on neuromuscular transmission in smooth muscle].
    Romanenko AV; Baidan LV; Khalmuradov AG; Shuba MF
    Fiziol Zh (1978); 1981; 27(1):34-6. PubMed ID: 6257560
    [No Abstract]   [Full Text] [Related]  

  • 43. [Diltiazem potentiation of neuromuscular blockage produced by pancuronium or succinylcholine].
    Hashimoto Y; Irimada T; Teshigawara T; Koga Y; Iwatsuki N
    Masui; 1986 Nov; 35(11):1689-93. PubMed ID: 3029451
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of SQ 31,765, a new calcium channel blocker, on stress and myosin light chain phosphorylation in swine carotid media.
    Moreland S; McMullen DM
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):609-15. PubMed ID: 1706802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Influence of verapamil and diltiazem on the muscle-relaxing effect of atracurium in vivo].
    Gómez Iglesias E; García Pascual E; Aguirre Gómez C; Rodríguez-Sasiaín JM; Calvo Duo R
    Rev Esp Anestesiol Reanim; 1991; 38(5):297-300. PubMed ID: 1665242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic effect of KB-944, a new calcium antagonist. A comparison with verapamil and diltiazem.
    Yoshidomi M; Sukamoto T; Morita T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1056-9. PubMed ID: 6890826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
    Godfraind T; Miller RC
    Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of receptor for advanced glycosylation end products (AGEP) and inhibition of AGEP-induced cytosolic calcium elevation by diltiazem in cultured rat aortic smooth muscle cells.
    Zhou QG; Liu NF; Xie PL
    Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):425-30. PubMed ID: 10322933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
    Schoemaker H; Boles RG; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of anemonotoxin on the neuromuscular transmission in skeletal and smooth muscle].
    Baĭdan LV; Kozlovskaia EP; Eliakov GB; Tishkin SM; Shuba MF
    Dokl Akad Nauk SSSR; 1981; 259(4):1000-2. PubMed ID: 6116588
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium channel blocking drugs.
    Johnston WE; Lowenstein E
    Contemp Anesth Pract; 1983; 7():163-91. PubMed ID: 6309475
    [No Abstract]   [Full Text] [Related]  

  • 53. Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blocker.
    Dodd JH; Schwender CF; Conley RA; Moore JB; Ritchie DM; Fabian AC; Fenk CJ; Bourcet E; Gray-Nunez Y; Kirchner T
    Drug Des Discov; 1993; 10(1):65-75. PubMed ID: 8399994
    [No Abstract]   [Full Text] [Related]  

  • 54. Relationship between extra and intracellular sources of calcium and the contractile effect of thiopental in rat aorta.
    Henkel CC; Asbun J; Ceballos G; del Carmen Castillo M; Castillo EF
    Can J Physiol Pharmacol; 2001 May; 79(5):407-14. PubMed ID: 11405244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonistic activity of verapamil and diltiazem against different intestinal smooth muscle stimuli.
    Samueli F; Bonabello A; Grassi A
    Arzneimittelforschung; 1984; 34(2):181-4. PubMed ID: 6539111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influences of Ca2+: antagonist and cyclic AMP on vascular smooth muscle cells in culture.
    Kuzuya F; Naito M; Asai KI; Shibata K
    Angiology; 1985 Sep; 36(9):622-7. PubMed ID: 2996387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular reactivity and calcium-entry blockers.
    Van Nueten JM; De Clerck F
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():575-83. PubMed ID: 6233852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of diltiazem, a calcium antagonist: coronary vasodilating and antihypertensive actions.
    Nagao T; Narita H; Sato M; Nakajima H; Kiyomoto A
    Clin Exp Hypertens A; 1982; 4(1-2):285-96. PubMed ID: 7074990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium channel blockers and smooth muscle motility in vitro.
    Gintautiene K; Matook AE; Abadir AR; Estafan MY; Bhangdia P; Silverstein JH; Gintautas J
    Proc West Pharmacol Soc; 1987; 30():141-3. PubMed ID: 3628266
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence for the site of action of glycerol trinitrate and diltiazem in inhibiting vasoconstrictor responses to norepinephrine in isolated renal arteries.
    Gross GJ; Gharaibeh MN
    Pharmacology; 1986; 32(1):1-10. PubMed ID: 2418448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.